Kilitch Drugs (India) Limited’s Subsidiary Won Tender Issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia - Mumbai (India), February 27: Kilitch Drugs (India) Limited, (BSE CODE:524500, NSE CODE: KILITCH), a multi-national pharmaceutical company based in Mumbai, has announced that its subsidiary, Kilitch Estro Biotech PLC, has secured a significant tender issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia having value of approx. USD 9.13 million. This tender win marks a notable achievement for the company not only because of this tender but also it will definitely repeat as the Ethiopian Pharmaceutical Supply Service has planned to purchase injectable from local manufacturer. - PNN Digital

Kilitch Drugs (India) Limited’s Subsidiary Won Tender Issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia

Mumbai (India), February 27: Kilitch Drugs (India) Limited, (BSE CODE:524500, NSE CODE: KILITCH), a multi-national pharmaceutical company based in Mumbai, has announced that its subsidiary, Kilitch Estro Biotech PLC, has secured a significant tender issued by the Ethiopian Pharmaceutical Supply Service of the Federal Democratic Republic of Ethiopia having value of approx. USD 9.13 million. This […]

Continue Reading

Kilitch Drugs (India) Limited Reports 69.87% Increase In Q4 Fy23 Profit

New Delhi (India), June 3: Kilitch Drugs India Limited is a Leading MSME multinational manufacturer of Injectable in India and Ethiopia, has announced its audited Financial Results for the Q4 & FY23. Financials at a Glance: Q4 FY23: • Total Revenue of ₹ 43.28 crore, YoY growth of 35.12% • EBITDA of ₹ 8.12 crore, YoY growth of 71.31% • EBITDA Margin is 18.76%, YoY growth of 396 Bps. • Net Profit of ₹ 5.13 crore, YoY growth of 69.87% […]

Continue Reading